Types of Manuscripts and Limits

Original Research

Original Articles are scientific reports of the results of original clinical research. The text is limited to 2700 words, with an abstract, a maximum of 5 tables and figures (total), and up to 40 references.

Special Articles are scientific reports of original research in such areas as economic policy, ethics, law, and health care delivery. The text is limited to 2700 words, with an abstract, a maximum of 5 tables and figures (total), and up to 40 references.

Cases Reports

Brief Reports usually describe one to three patients or a single family. The text is limited to 2000 words, a maximum of 3 tables and figures (total), and up to 25 references. They begin with a brief summary of no more than 100 words.

Clinical Problem-Solving manuscripts consider the step-by-step process of clinical decision making. Information about a patient is presented to an expert clinician or clinicians in stages (indicated by boldface type in the manuscript) to simulate the way such information emerges in clinical practice. The clinician responds (in regular type) as new information is presented, sharing his or her reasoning with the reader. The text should not exceed 2500 words, and there should be no more than 20 references. The use of clinical illustrative materials, such as x-ray films, is encouraged.

Review Articles

Review articles are usually solicited by the editors, but we will consider unsolicited material. All review articles undergo the same peer-review and editorial process as original research reports. They should be written for the general physician, not specialists. Consequently, they may include material that might be considered too introductory for specialists in the field being covered.

Conflicts of Interest: Because the essence of review articles is selection and interpretation of the literature, the Journal expects that the authors of such articles will not have significant financial associations with a company (or its competitor) that makes a product discussed in the article.

Clinical Practice articles are evidence-based reviews of topics relevant to practicing physicians, both primary care providers and specialists. Articles in this series should include the following sections: the clinical problem, strategies and evidence, areas of uncertainty, guidelines from professional societies, and the authors' conclusions and recommendations. The text is limited to 2500 words and a small number of figures and tables. These articles do not include an abstract.

Clinical Therapeutics articles are evidence-based reviews of topics relevant to practicing physicians. The series focuses on clinically oriented information about specific forms of therapy, including drugs, devices, and procedures. Each article in the series begins with a clinical vignette describing a patient with a specified condition for whom the treatment under discussion has been recommended. This vignette is followed by a definition of the clinical problem, a description of the pathophysiology and how the therapy works, clinical evidence, clinical use (including costs), adverse effects, areas of uncertainty, guidelines, and recommendations. The text is limited to 2500 words. These articles do not include an abstract.

Current Concepts articles focus on clinical topics, including those in specialty areas but of wide interest. The text is limited to 2400 words, with a maximum of 4 figures and tables (total), and up to 50 references. These articles do not include an abstract.

Drug Therapy articles detail the pharmacology and use of specific drugs or classes of drugs, or the various drugs used to treat particular diseases. The text is limited to 3300 words, with a maximum of 5 figures and tables (total), and up to 100 references. These articles do not include an abstract.

Mechanisms of Disease articles discuss the cellular and molecular mechanisms of diseases or categories of diseases. The text is limited to 3000 words, with a maximum of 5 figures and tables (total), and up to 100 references. These articles do not include an abstract.

Medical Progress articles provide comprehensive, scholarly overviews of important clinical subjects, with the principal (but not exclusive) focus on developments during the past five years. Each article details how the perception of a disease, disease category, diagnostic approach, or therapeutic intervention has evolved in recent years. The text is limited to 3300 words, with a maximum of 5 tables and figures (total), and up to 100 references. These articles do not include an abstract.

Letter to the Editor

Letters to the Editor provide a forum for readers to comment about articles recently published in the Journal, and they are a place to publish concise articles, such as reports of novel cases. Letters to the Editor are considered for publication (subject to editing and abridgment) provided they do not contain material that has been submitted or published elsewhere.

Letters in reference to a Journal article must not exceed 175 words (excluding references), and must be received within three weeks after publication of the article. Letters not related to a Journal article must not exceed 400 words (excluding references).

A letter can have no more than five references and one figure or table.

A letter can be signed by no more than three authors.

You will be asked to include your full address, telephone number, mobile number, and e-mail address. Financial associations or other possible conflicts of interest must be disclosed. You will receive an e-mailed acknowledgment of your submission. Additional information may also be found in our Frequently Asked Questions.

Other Submissions

Editorials usually provide commentary and analysis concerning an article in the issue of the Journal in which they appear. They may include 1 figure or table. They are nearly always solicited, although unsolicited editorials may occasionally be considered. Editorials are limited to 750 words, with up to 10 references.

Perspective articles cover a wide variety of topics of current interest in health care, medicine, and the intersection between medicine and society. We welcome submissions and proposals. Perspective articles are limited to 1000 to 1200 words and usually include one figure. There is a maximum of 5 references.

Sounding Board articles are opinion essays. They are similar to editorials but are not tied to a particular article. They often present opinions on health policy issues and are normally unsolicited. The text is limited to 2000 words.

Clinical Implications of Basic Research articles discuss single papers from preclinical journals. The purpose is to explain the findings and comment on their possible clinical applications in fewer than 750 words. There may be 1 figure and up to 5 references. We do not consider unsolicited manuscripts in this category.

Special Reports are miscellaneous articles of special interest to the medical community. They are limited to 2700 words.

Health Law, Ethics, and Human Rights are nearly always solicited, but we are willing to consider unsolicited manuscripts or proposals for manuscripts.

Health Policy Reports are nearly always solicited, but we are willing to consider unsolicited manuscripts or proposals for manuscripts.

Occasional Notes are accounts of personal experiences or descriptions of material from outside the usual areas of medical research and analysis.

Images in Clinical Medicine are classic images of common medical conditions. Images are an important part of much of what we do and learn in medicine. This feature is intended to capture the sense of visual discovery and variety that physicians experience. Images in Clinical Medicine are not intended as a vehicle for case reports.

Filler Photographs are unsolicited photographs, unrelated to the content of the Journal, that are published as space allows. There are no restrictions on subject matter, however photographs of recognizable people are not generally published.

Requirements:

• Photo files must be submitted in JPEG format and have a file extension of .jpg or .jpeg.
• Photos must be 1000 x 1000 pixels minimum to be considered for publication. To be eligible to be printed at the largest size, images should be 1730 pixels wide by 2000 pixels high or larger.
• Photo files may be up to 10 MB in size.
• A maximum of five photos may be uploaded per session.

After submitting a photo you will be notified by email once it has been reviewed by our editors. You will also receive email notification if your photo is selected for publication.

Last Updated on 04 October, 2023

Preparaon of the Manuscript

Covering Letter

Prepare the title page, covering letter, acknowledgement, etc. using a word processor program. All information which can reveal your identity should be here.

The text of observational and experimental articles should be divided into sections with the headings: Introduction, Methods, Results, Discussion, References, Tables, Figures, Figure legends, and Acknowledgment. Do not make subheadings in these sections.

Title Page

The title page should carry

1. Type of manuscript (e.g. Original article, Review article, Case Report etc.);
2. The title of the article, which should be concise, but informative;
3. Running title or short title not more than 50 characters;
4. The name by which each contributor is known (Last name, First name and initials of middle name), with his or her highest academic degree(s) and institutional affiliation;
5. The name of the department(s) and institution(s) to which the work should be attributed;
6. The name, address, phone numbers, mobile numbers and e-mail address of the contributor responsible for correspondence about the manuscript;
7. The total number of pages, total number of photographs and word counts separately for abstract and for the text (excluding the references and abstract);
8. Source(s) of support in the form of grants, equipment, drugs, or all of these;
9. Acknowledgement, if any; and

1. If the manuscript was presented as part of a meeting, the organization, place, and exact date on which it was read.

Abstract Page

The second page should carry the full title of the manuscript and an abstract (of no more than 150 words for case reports, brief reports and 250 words for original articles). The abstract should be structured and state the Context (Background), Aims, Settings and Design, Methods and Material, Statistical analysis used, Results and Conclusions. Below the abstract should provide 3 to 10 keyword.

Introduction

State the purpose of the article and summarize the rationale for the study or observation.

Methods

The methods section should include only information that was available at the time the plan or protocol for the study was written; all information obtained during the conduct of the study belongs in the Results section.

Reports of randomized clinical trials should be based on the CONSORT Statement. When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2013.

Results

Present your results in logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Extra or supplementary materials and technical detail can be placed in an appendix where it will be accessible but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal.

Discussion

Include Summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence (is there a systematic review to refer to, if not, could one be reasonably done here and now?, what this study adds to the available evidence, effects on patient care and health policy, possible mechanisms); Controversies raised by this study; and Future research directions (for this particular research collaboration, underlying mechanisms, clinical research). Do not repeat in detail data or other material given in the Introduction or the Results section.

References

List references in alphabetical order. Each listed reference should be cited in text (not in alphabetic order), and each text citation should be listed in the References section. Identify references in text, tables, and legends by Arabic numerals in square bracket (e.g. [10]). Please refer to ICMJE Guidelines for more examples.

Standard journal article

[1] Flink H, Tegelberg Å, Thörn M, Lagerlöf F. Effect of oral iron supplementation on unstimulated salivary flow rate: A randomized, double-blind, placebo-controlled trial. J Oral Pathol Med 2006;35:540-7.

[2] Twetman S, Axelsson S, Dahlgren H, Holm AK, Källestål C, Lagerlöf F, et al. Caries-preventive effect of fluoride toothpaste: A systematic review. Acta Odontol Scand 2003;61:347-55.

Article in supplement or special issue

[3] Fleischer W, Reimer K. Povidone iodine antisepsis. State of the art. Dermatology 1997;195 Suppl 2:3-9.

Corporate (collective) author

[4] American Academy of Periodontology. Sonic and ultrasonic scalers in periodontics. J Periodontol 2000;71:1792-801.

Unpublished article

[5] Garoushi S, Lassila LV, Tezvergil A, Vallittu PK. Static and fatigue compression test for particulate filler composite resin with fiber-reinforced composite substructure. Dent Mater 2006.

Personal author(s)

[6] Hosmer D, Lemeshow S. Applied logistic regression, 2^nd edn. New York: Wiley-Interscience; 2000.

Chapter in book

[7] Nauntofte B, Tenovuo J, Lagerlöf F. Secretion and composition of saliva. In: Fejerskov O, Kidd EAM, editors. Dental caries: The disease and its clinical management. Oxford: Blackwell Munksgaard; 2003. p. 7-27.

No author given

[8] World Health Organization. Oral health surveys - basic methods, 4^th edn. Geneva: World Health Organization; 1997.

Reference from electronic media

[9] National Statistics Online—Trends in suicide by method in England and Wales, 1979-2001. www.statistics.gov.uk/downloads/theme_health/HSQ 20.pdf (accessed Jan 24, 2005): 7-18. Only verified references against the original documents should be cited. Authors are responsible for the accuracy and completeness of their references and for correct text citation. The number of reference should be kept limited to 20 in case of major communications and 10 for short communications.

More information about other reference types is available at, but observes some minor deviations (no full stop after journal title, no issue or date after volume, etc).

Tables

1. Tables should be self-explanatory and should not duplicate textual material.
2. Tables with more than 10 columns and 25 rows are not acceptable.
3. Number tables, in Arabic numerals, consecutively in the order of their first citation in the text and supply a brief title for each.
4. Explain in footnotes all non-standard abbreviations that are used in each table.
5. For footnotes use the following symbols, in this sequence: *, ¶, †, ‡‡,

Illustrations (Figures)

1. Graphics files are welcome if supplied as Tiff, EPS, or PowerPoint files of minimum 1200x1600 pixel size. The minimum line weight for line art is 0.5 point for optimal printing.
2. When possible, please place symbol legends below the figure instead of to the side.
3. Original color figures can be printed in color at the editor's and publisher's discretion provided the author agrees to pay
4. Type or print out legends (maximum 40 words, excluding the credit line) for illustrations using double spacing, with Arabic numerals corresponding to the illustrations.

Sending a revised manuscript

While submitting a revised manuscript, contributors are requested to include, along with single copy of the final revised manuscript, a photocopy of the revised manuscript with the changes underlined in red and copy of the comments with the point to point clarification to each comment. The manuscript number should be written on each of these documents. If the manuscript is submitted online, the contributors’ form and copyright transfer form has to be submitted in original with the signatures of all the contributors within two weeks of submission. Hard copies of images should be sent to the office of the journal. There is no need to send printed manuscript for articles submitted online.

Reprints

Journal provides no free printed reprints, however an author copy is sent to the main author and additional copies are available on payment (ask to the journal office).

Copyrights

The whole of the literary matter in the journal is copyright protected and cannot be reproduced without the written permission of the publisher.

Copyright Form can be downloaded from the DOWNLOADS section

Declaration

A declaration should be submitted stating that the manuscript represents valid work and that neither this manuscript nor one with substantially similar content under the present authorship has been published or is being considered for publication elsewhere and the authorship of this article will not be contested by anyone whose name (s) is/are not listed here, and that the order of authorship as placed in the manuscript is final and accepted by the co-authors. Declarations should be signed by all the authors in the order in which they are mentioned in the original manuscript. Matters appearing in the Journal are covered by copyright but no objection will be made to their reproduction provided permission is obtained from the Editor prior to publication and due acknowledgment of the source is made.

Declaration Form can be downloaded from the DOWNLOADS section

Abbreviations

Standard abbreviations should be used and be spelt out when first used in the text. Abbreviations should not be used in the title or abstract.

Checklist

Authors

• Middle name initials provided.
• Author for correspondence, with e-mail address provided.
• Number of contributors restricted as per the instructions
• Identity not revealed in paper except title page {e.g. name of the institute in Methods, citing previous study as ‘our study’)

Presentation and Format

• Double spacing
• Margins 2.5 cm from all four sides
• Title page contains all the desired information. Running title provided (not more than 50 characters)
• Abstract page contains the full title of the manuscript
• Abstract provided: Structured abstract provided for an original article.
• Key words provided (three or more)
• Introduction of 75-100 words
• Headings in title case (not ALL CAPITALS). References cited in square brackets
• References according to the journal's instructions

Language and grammar

• Uniformly American English
• Abbreviations spelt out in full for the first time. Numerals from 1 to l0 spelt out
• Numerals at the beginning of the sentence spelt out

Tables and figures

• No repetition of data in tables and graphs and in text.
• Actual numbers from which graphs drawn, provided.
• Figures necessary and of good quality (color)
• Table and figure numbers in Arabic letters (not Roman).
• Labels pasted on back of the photographs (no names written), in case of printed manuscript
• Figure legends provided (not more than 40 words)
• Patients' privacy maintained, (if not permission taken)
• Credit note for borrowed figures/tables provided
• Manuscript provided with double spacing

Submitting the Manuscript

• Is the journal editor’s contact information current?
• Is a cover letter included with the manuscript?
• Does the letter include the author’s postal address, e-mail address, telephone number, and mobile number for future correspondence?
• State that the manuscript is original, not previously published, and not under concurrent consideration elsewhere?
• Is Informed the journal editor of the existence of any similar published manuscripts written by the author?
• Mention any supplemental material you are submitting for the online version of your article?

Last Updated on 04 October, 2023

Author Agreement form for contributors

The form below is for contributors to the journal to complete and submit once it is confirmed that their submission will be published in a forthcoming issue. It is also intended for contributors to prior issues who have not yet filled out an author agreement form. Please take care to fill out this form correctly, as there are no warnings on incomplete fields; and if done incorrectly it will need to be recompleted.

Please download all these documents and return scanned copies of completed and duly signed by all authors must be e-mail to us.

In case you made this article from your thesis; please download this document ‘Undertaking Article Made From Thesis’ and return completed and duly signed by all authors through email to us.

Send the Corrected Proof, and Subscriptions (If any) with covering letter in a single envelope to the following address.

Important Contact Details

Authorship & contributorship

Authorship

The International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations 2018) recommend that authorship be based on the following four criteria:

• Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
• Drafting the work or revising it critically for important intellectual content; AND
• Final approval of the version to be published; AND
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

We include only one corresponding author per article. Any further contribution details (eg, equal contribution) must be included in the contributors or acknowledgement sections at the end of the article.

The RED FLOWER PUBLICATIONS requires that all those designated as authors should meet all four ICMJE criteria for authorship, and all who meet the four criteria should be identified as authors. We recognise only natural persons over 18 years of age as authors. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #s 2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.

The individuals who conduct the work are responsible for identifying who meets these criteria and ideally should do so when planning the work, making modifications as appropriate as the work progresses. The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more co-authors.

When a large multi-author group has conducted the work, the group ideally should decide who will be an author before the work is started and confirm who is an author before submitting the manuscript for publication. All members of the group named as authors should meet all four criteria for authorship, including approval of the final manuscript, and they should be able to take public responsibility for the work and should have full confidence in the accuracy and integrity of the work of other group authors. They will also be expected as individuals to complete conflict-of-interest disclosure forms.

The by line of the article identifies who is directly responsible for the manuscript, and Medline lists as authors whichever names appear on the by line. If the by line includes a group name, Medline will list the names of individual group members who are authors or who are collaborators, sometimes called non-author contributors, if there is a note associated with the by line clearly stating that the individual names are elsewhere in the paper and whether those names are authors or collaborators.

At The RED FLOWER PUBLICATIONS we want authors to assure us that all authors included on a paper fulfil the criteria of authorship. In addition we want assurance that there is no one else who fulfils the criteria but has not been included as an author.

When we encounter disagreements among authors we follow guidance from the Committee on Publication Ethics (COPE)—see here and here.

Contributorship

The RED FLOWER PUBLICATIONS lists contributors in two ways. Firstly, we publish a list of authors' names at the beginning of the paper and, secondly, we list contributors (some of whom may not be included as authors) at the end of the paper, giving details of who did what in planning, conducting, and reporting the work. This is a good place to include contributions by patients or members of the public who have assisted as research volunteers, giving their names and specific roles. We encourage authors to fully acknowledge the contribution of patients and the public to their research where appropriate.

One or more of these contributors are listed as guarantors of the paper. The guarantor accepts full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish.

Contributorship and guarantorship are concepts that were applied first to original research papers, and are sometimes hard to define for other articles. Each contributorship statement should make clear who has contributed what to the planning, conduct, and reporting of the work described in the article, and should identify one, or occasionally more, contributor(s) as being responsible for the overall content as guarantor(s). For articles in The RED FLOWER PUBLICATIONS that do not report original research - such as editorials, clinical reviews, and education and debate - please state who had the idea for the article, who performed the literature search, who wrote the article, and who is the guarantor (the contributor who accepts full responsibility for the finished article, had access to any data, and controlled the decision to publish). For non-research articles that include case reports such as lessons of the week, drug points, and interactive case reports, please also state who identified and/or managed the case(s).

Researchers must determine among themselves the precise nature of each person's contribution, and we encourage open discussion among all participants.

Alteration to authorship or contributorship

Any change in authors and/or contributors after initial submission must be approved by all authors. This applies to additions, deletions, change of order to the authors, or contributions being attributed differently. Any alterations must be explained to the editor. The editor may contact any of the authors and/or contributors to ascertain whether they have agreed to any alteration.

Group authorship

If there is a very large number of authors we may ask for confirmation that everyone listed met the ICMJE criteria for authorship. If they did, we may then require that the authors form a group whose name will appear in the article by line.

We appreciate that authors may be concerned that their work will not be properly recognised if they form a group, but this is unfounded. Medline guidance can handle group authorship and still give each individual due credit:

"When a group name for a specific consortium, committee, study group, or the like appears in an article by line, the personal names of the members of that group may be published in the article text. Such names are entered as collaborator names for the Medline citation."

Key points:

• A Medline citation may contain an array of personal author names, group (or corporate) author names, and collaborator names.
• Personal author names are included in Medline when the author names appear in the article by line, or are explicitly identified anywhere else in the text of the article as the authors or as the members of the writing group or writing committee for the article.
• Group author names (also known as corporate, organization or collective names) are included in Medline when such names appear in the article by line.
• When a group name for a specific consortium, committee, study group, or the like appears in an article by line, the personal names of the members of that group may be published in the article text. Such names are entered as collaborator names for the Medline citation.
• Collaborator names are entered for a Medline citation only when a group (corporate) author name is present for the citation.
• More than one group name may appear for a citation, and a group name may appear along with personal author names.
• For articles that represent a formal guideline or practice guideline, the name of the guideline-issuing body is entered as a group name for the Medline citation, even if that name does not appear in the article by line.

What this means for The RED FLOWER PUBLICATIONS's authors

a) if authors form a group for the article's main by line they will also be listed individually:

• As collaborators in the article's Medline/PubMed record;
• As authors in a group authorship statement at the end of the article on the rfppl.co.in; and
• As contributors in the contributorship statement at the end of the article on the rfppl.co.in.

b) however, for The RED FLOWER PUBLICATIONS's research articles with many authors, where those authors do not opt to form a group, we will not be able to publish a RED FLOWER PUBLICATIONS pico in the print issue of The RED FLOWER PUBLICATIONS. Such research articles will be for online only (the rfppl.co.in) publication only.

Last Updated on 04 October, 2023

Disclaimer and Copyrights

The entire contents are protected under international copyrights.

Important notice on reuse, reproduction or commercial use:

• Contents of this site, partial or as a whole, should not be included in a framed web page.
• Contents of this site, partial or as a whole, should not be included in a password protected site or a site which requires registration, even if free.
• Contents of this site, partial or as a whole, should not be included in a site which charges for other contents but provides the content from this site for free.
• For purchase of reprints, printable PDF or commercial reuse please contact Red Flower Publications or the executive editor of the journal.

All material published in the journal undergoes peer review to ensure fair balance, objectivity, independence, and relevance to educational need. Neither the editors of Journal title, nor its publishers, nor any other party involved in the preparation of material contained in represent or warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such material. Patients and consumers reading articles posted on the website of Journal title should review the information carefully with their professional healthcare provider. The information is not intended to replace medical advice offered by the physicians. Journal title and its publishers make no representations or warranties with respect to any treatment, action, or application of medication or preparation by any person following the information offered or provided. The Journal title and its publishers will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising there from.

The advertisers who purchase Banners on the have no influence on editorial content or presentation. The posting of particular Banners does not imply endorsement of the product (so) or the company selling them by the Journal title or its Editors.

This may contain links to web sites operated by other parties. These links are provided purely for educational purpose. Such links do not imply Journal title's endorsement of material on any other site and disclaims all liability with regard to your access of such linked web sites.

Author Agreement form for contributors

The form below is for contributors to the journal to complete and submit once it is confirmed that their submission will be published in a forthcoming issue. It is also intended for contributors to prior issues who have not yet filled out an author agreement form. Please take care to fill out this form correctly, as there are no warnings on incomplete fields; and if done incorrectly it will need to be recompleted.

Please download all these documents and return scanned copies of completed and duly signed by all authors must be e-mail to us.

In case you made this article from your thesis; please download this document ‘Undertaking Article Made From Thesis’ and return completed and duly signed by all authors through email to us.

Send the Corrected Proof, and Subscriptions (If any) with covering letter in a single envelope to the following address.

Important Contact Details

Last Updated on 04 October, 2023

Author-Suggested Reviewers

The authors are encouraged to suggest individuals who specialize in the topic(s) your manuscript to be considered to review. You may suggest maximum of 5 reviewers, with full contact details including phone numbers, mobile number and email address.

Last Updated on 04 October, 2023

Online Submission of the Manuscripts

Manuscripts should always be submitted via web based manuscript submission system and also can be sent through e-mail attachments to this mail.

Author Registration and Submissions

Visit this page

1. First Page File: Prepare the title page, covering letter, acknowledgement, etc. using a word processor program. All information which can reveal your identity should be here. Use text/rtf/doc files. Do not zip the files.
2. Article file: The main text of the article, beginning from Abstract till References (including tables) should be in this file. Do not include any information (such as acknowledgement, your name in page headers, etc.) in this file. Use text/rtf/doc files. Do not zip the files. Limit the file size to 400 kb. Do not incorporate images in the file. If file size is large, graphs can be submitted as images separately without incorporating them in the article file to reduce the size of the file.
3. Images: Submit good quality color images. Each image should be less than 100 kb in size. Size of the image can be reduced by decreasing the actual height and width of the images (keep up to 400 pixels or 3 inches). All image formats (jpeg, tiff, gif, bmp, png, eps etc.) are acceptable; jpeg is most suitable.
4. Legends: Legends for the figures/images should be included at the end of the article file.

If the manuscript is submitted online, the contributors' form and copyright transfer form has to be submitted in original with the signatures of all the contributors within two weeks from submission. No need of hard copies of the images, if articles submitted online or sent through e-mail.

Important Contact Details

Last Updated on 04 October, 2023

Acknowledgments

All messages and reviews sent electronically will be acknowledged electronically upon receipt. Please supply any information you think may be helpful in replying electronically. If you do not receive an acknowledgement one week after submission, assume that the message did not reach the editorial office of the journal. Please wait and do not send multiple messages, because it takes much work to eliminate double mail.

Note : e-mails with the forcibly consideration, multiple queries on status, vicious language, offensive writings to Editor/Associate Editors will lead to rejection of Manuscript.

Last Updated on 04 October, 2023

Article withdrawal, Retraction, Removal & Replacement

Red Flower Publication recognizes the importance of the integrity and completeness of the scholarly record to researchers and librarians and attaches the highest importance to maintaining trust in the authority of its electronic archive.

Red Flower Publication's policy

It is a general principle of scholarly communication that the editor of a learned journal is solely and independently responsible for deciding which articles submitted to the journal shall be published. In making this decision the editor is guided by policies of the journal's editorial board and constrained by such legal requirements in force regarding libel, copyright infringement and plagiarism. An outcome of this principle is the importance of the scholarly archive as a permanent, historic record of the transactions of scholarship. Articles that have been published shall remain extant, exact and unaltered as far as is possible. However, very occasionally circumstances may arise where an article is published that must later be retracted or even removed. Such actions must not be undertaken lightly and can only occur under exceptional circumstances.

This policy has been designed to address these concerns and to take into account current best practice in the scholarly and library communities. As standards evolve and change, we will revisit this issue and welcome the input of scholarly and library communities. We believe these issues require international standards and we will be active in lobbying various information bodies to establish international standards and best practices that the publishing and information industries can adopt.

Article Withdrawal

Only used for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Articles in Press (articles that have been accepted for publication but which have not been formally published and will not yet have the complete volume/issue/page information) that include errors, or are discovered to be accidental duplicates of other published article(s), or are determined to violate our journal publishing ethics guidelines in the view of the editors (such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like), may be "Withdrawn" from us. Withdrawn means that the article content (HTML and PDF) is removed and replaced with a HTML page and PDF simply stating that the article has been withdrawn according to the Red Flower Publication Policy on Article in Press Withdrawal with a link to the current policy document.

Article Retraction

Infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Occasionally a retraction will be used to correct errors in submission or publication. The retraction of an article by its authors or the editor under the advice of members of the scholarly community has long been an occasional feature of the learned world. Standards for dealing with retractions have been developed by a number of library and scholarly bodies, and this best practice is adopted for article retraction by Red Flower Publications:

• A retraction note titled "Retraction: [article title]" signed by the authors and/or the editor is published in the paginated part of a subsequent issue of the journal and listed in the contents list.
• In the electronic version, a link is made to the original article.
• The online article is preceded by a screen containing the retraction note. It is to this screen that the link resolves; the reader can then proceed to the article itself.
• The original article is retained unchanged save for a watermark on the .pdf indicating on each page that it is "retracted."
• The HTML version of the document is removed.

Article Removal: Legal limitations

In an extremely limited number of cases, it may be necessary to remove an article from the online database. This will only occur where the article is clearly defamatory, or infringes others legal rights, or where the article is, or we have good reason to expect it will be, the subject of a court order, or where the article, if acted upon, might pose a serious health risk. In these circumstances, while the metadata (Title and Authors) will be retained, the text will be replaced with a screen indicating the article has been removed for legal reasons.

Article Replacement

In cases where the article, if acted upon, might pose a serious health risk, the authors of the original article may wish to retract the flawed original and replace it with a corrected version. In these circumstances the procedures for retraction will be followed with the difference that the database retraction notice will publish a link to the corrected re-published article and a history of the document.

Last Updated on 04 October, 2023

Duties of Editors

Fair play and editorial independence

Editors evaluate submitted manuscripts exclusively on the basis of their academic merit (importance, originality, study’s validity, clarity) and its relevance to the journal’s scope, without regard to the authors’ race, gender, sexual orientation, ethnic origin, citizenship, religious belief, political philosophy or institutional affiliation. Decisions to edit and publish are not determined by the policies of governments or any other agencies outside of the journal itself. The Editor-in-Chief has full authority over the entire editorial content of the journal and the timing of publication of that content.

Confidentiality

Editors and editorial staff will not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest

Editors and editorial board members will not use unpublished information disclosed in a submitted manuscript for their own research purposes without the authors’ explicit written consent. Privileged information or ideas obtained by editors as a result of handling the manuscript will be kept confidential and not used for their personal advantage. Editors will recuse themselves from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships/connections with any of the authors, companies or institutions connected to the papers; instead, they will ask another member of the editorial board to handle the manuscript.

Publication decisions

The editors ensure that all submitted manuscripts being considered for publication undergo peer-review by at least two reviewers who are expert in the field. The Editor-in-Chief is responsible for deciding which of the manuscripts submitted to the journal will be published, based on the validation of the work in question, its importance to researchers and readers, the reviewers’ comments, and such legal requirements as are currently in force regarding libel, copyright infringement and plagiarism. The Editor-in-Chief may confer with other editors or reviewers in making this decision.

Involvement and cooperation in investigations

Editors (in conjunction with the publisher and/or society) will take responsive measures when ethical concerns are raised with regard to a submitted manuscript or published paper. Every reported act of unethical publishing behavior will be looked into, even if it is discovered years after publication. Red Flower Publication follow the COPE Flowcharts when dealing with cases of suspected misconduct. If, on investigation, the ethical concern is well-founded, a correction, retraction, expression of concern or other note as may be relevant will be published in the journal.

Duties of Reviewers

Contribution to editorial decisions

Peer review assists editors in making editorial decisions and, through editorial communications with authors, may assist authors in improving their manuscripts. Peer review is an essential component of formal scholarly communication and lies at the heart of scientific endeavor. Red Flower Publication shares the view of many that all scholars who wish to contribute to the scientific process have an obligation to do a fair share of reviewing.

Promptness

Any invited referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should immediately notify the editors and decline the invitation to review so that alternative reviewers can be contacted.

Confidentiality

Any manuscripts received for review are confidential documents and must be treated as such; they must not be shown to or discussed with others except if authorized by the Editor-in-Chief (who would only do so under exceptional and specific circumstances). This applies also to invited reviewers who decline the review invitation.

Standards of objectivity

Reviews should be conducted objectively and observations formulated clearly with supporting arguments so that authors can use them for improving the manuscript. Personal criticism of the authors is inappropriate.

Acknowledgment of sources

Reviewers should identify relevant published work that has not been cited by the authors. Any statement that is an observation, derivation or argument that has been reported in previous publications should be accompanied by the relevant citation. A reviewer should also notify the editors of any substantial similarity or overlap between the manuscript under consideration and any other manuscript (published or unpublished) of which they have personal knowledge.

Disclosure and conflicts of interest

Any invited referee who has conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies or institutions connected to the manuscript and the work described therein should immediately notify the editors to declare their conflicts of interest and decline the invitation to review so that alternative reviewers can be contacted.

Unpublished material disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the authors. Privileged information or ideas obtained through peer review must be kept confidential and not used for the reviewer’s personal advantage. This applies also to invited reviewers who decline the review invitation.

Duties of Authors

Reporting standards

Authors of original research should present an accurate account of the work performed and the results, followed by an objective discussion of the significance of the work. The manuscript should contain sufficient detail and references to permit others to replicate the work. Review articles should be accurate, objective and comprehensive, while editorial 'opinion' or perspective pieces should be clearly identified as such. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Data access and retention

Authors may be asked to provide the raw data of their study together with the manuscript for editorial review and should be prepared to make the data publicly available if practicable. In any event, authors should ensure accessibility of such data to other competent professionals for at least 10 years after publication (preferably via an institutional or subject-based data repository or other data center), provided that the confidentiality of the participants can be protected and legal rights concerning proprietary data do not preclude their release.

Originality and plagiarism

Authors should ensure that they have written and submit only entirely original works, and if they have used the work and/or words of others, that this has been appropriately cited. Publications that have been influential in determining the nature of the work reported in the manuscript should also be cited. Plagiarism takes many forms, from "passing off" another's paper as the author's own, to copying or paraphrasing substantial parts of another's paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable.

Multiple, duplicate, redundant or concurrent submission/publication

Papers describing essentially the same research should not be published in more than one journal or primary publication. Hence, authors should not submit for consideration a manuscript that has already been published in another journal. Submission of a manuscript concurrently to more than one journal is unethical publishing behavior and unacceptable.

The publication of some kinds of articles (such as clinical guidelines, translations) in more than one journal is sometimes justifiable, provided that certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication.

Authorship of the manuscript

Only persons who meet these authorship criteria should be listed as authors in the manuscript as they must be able to take public responsibility for the content: (i) made significant contributions to the conception, design, execution, data acquisition, or analysis/interpretation of the study; and (ii) drafted the manuscript or revised it critically for important intellectual content; and (iii) have seen and approved the final version of the paper and agreed to its submission for publication. All persons who made substantial contributions to the work reported in the manuscript (such as technical help, writing and editing assistance, general support) but who do not meet the criteria for authorship must not be listed as an author, but should be acknowledged in the "Acknowledgments" section after their written permission to be named as been obtained. The corresponding author should ensure that all appropriate coauthors (according to the above definition) and no inappropriate coauthors are included in the author list and verify that all coauthors have seen and approved the final version of the manuscript and agreed to its submission for publication.

Disclosure and conflicts of interest

Authors should—at the earliest stage possible (generally by submitting a disclosure form at the time of submission and including a statement in the manuscript)—disclose any conflicts of interest that might be construed to influence the results or their interpretation in the manuscript. Examples of potential conflicts of interest that should be disclosed include financial ones such as honoraria, educational grants or other funding, participation in speakers’ bureaus, membership, employment, consultancies, stock ownership, or other equity interest, and paid expert testimony or patent-licensing arrangements, as well as non-financial ones such as personal or professional relationships, affiliations, knowledge or beliefs in the subject matter or materials discussed in the manuscript. All sources of financial support for the work should be disclosed (including the grant number or other reference number if any).

Acknowledgment of sources

Authors should ensure that they have properly acknowledged the work of others, and should also cite publications that have been influential in determining the nature of the reported work. Information obtained privately (from conversation, correspondence or discussion with third parties) must not be used or reported without explicit, written permission from the source. Authors should not use information obtained in the course of providing confidential services, such as refereeing manuscripts or grant applications, unless they have obtained the explicit written permission of the author(s) of the work involved in these services.

Hazards and human or animal subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the authors must clearly identify these in the manuscript. If the work involves the use of animals or human participants, the authors should ensure that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) has approved them; the manuscript should contain a statement to this effect. Authors should also include a statement in the manuscript that informed consent was obtained for experimentation with human participants. The privacy rights of human participants must always be observed.

Peer review

Authors are obliged to participate in the peer review process and cooperate fully by responding promptly to editors’ requests for raw data, clarifications, and proof of ethics approval, patient consents and copyright permissions. In the case of a first decision of "revisions necessary", authors should respond to the reviewers’ comments systematically, point by point, and in a timely manner, revising and re-submitting their manuscript to the journal by the deadline given.

Fundamental errors in published works

When authors discover significant errors or inaccuracies in their own published work, it is their obligation to promptly notify the journal’s editors or publisher and cooperate with them to either correct the paper in the form of an erratum or to retract the paper. If the editors or publisher learns from a third party that a published work contains a significant error or inaccuracy, then it is the authors’ obligation to promptly correct or retract the paper or provide evidence to the journal editors of the correctness of the paper. For guidelines on retracting or correcting articles, please click here: http://rfppl.co.in/article_submission_system.php?mid=5#articlewithdrawal.

Duties of the Publisher

Handling of unethical publishing behavior

In cases of alleged or proven scientific misconduct, fraudulent publication or plagiarism, the publisher, in close collaboration with the editors, will take all appropriate measures to clarify the situation and to amend the article in question. This includes the prompt publication of an erratum, clarification or, in the most severe case, the retraction of the affected work. The publisher, together with the editors, shall take reasonable steps to identify and prevent the publication of papers where research misconduct has occurred, and under no circumstances encourage such misconduct or knowingly allow such misconduct to take place.

Access to journal content

The publisher is committed to the permanent availability and preservation of scholarly research and ensures accessibility by partnering with organizations and maintaining our own digital archive. For details on Red Flower Publication’s archiving policy, please click here: http://rfppl.co.in/archiveJournal.php?mid=21.

Advertising Policy

• All advertisements are subject to approval of the Red Flower Publication, which reserves the right to reject or cancel any ad at any time.
  
  
• All advertisements are accepted and published by Publisher on the warranty of the agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  
  
• In consideration of publication of an advertisement, the advertiser and the agency, jointly and severally, agree to indemnify and hold harmless Publisher, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement or plagiarism.
  
  
• Publisher will not be liable for any failure to publish any advertisement accepted by Publisher; however, Publisher shall use its reasonable efforts to place such advertisement in subsequent available space.
  
  
• All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  
  
• For advertorial guidelines contact your Sales Manager.
  
  
• Any references to Publisher or its products or services in advertisements, promotional material or merchandising by the advertiser or agency are subject to Publisher’s written approval for such use.
  
  
• All advertising contract position clauses are treated as requests. Publisher cannot guarantee fixed positioning.
  
  
• Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an ad.
  
  
• Publisher may change the terms set forth herein at any time, provided that no such change applies to ads whose closing date precedes the announcement of the change.
  
  
• Publisher will not be bound by any condition, printed or otherwise, appearing on any insertion order or copy instructions when such conditions conflict with the conditions set forth in this rate card.
  
  
• In the event of nonpayment, Publisher reserves the right to hold advertiser and/or its advertising agency jointly and severally liable for such monies as are past due and payable to Publisher.
  
  
• Proprietary names of pharmaceutical products must be accompanied by the chemical, generic or official name; the quantity of all active substances must be stated along with the recommended dosage. New ad copy and creative for pharmaceutical products should be sent to the advertising department. Please allow two weeks for clearance.
  
  
• All advertisements must be clearly germane to the practice of medicine.
  
  
• Advertiser represents and warrants that all advertisements and pharmaceutical products they advertise are compliant with all applicable laws, rules, and regulations in the country where the advertisement will be seen. Advertisements for pharmaceutical products (including NDA products) that are subject to India Food and Drug Administration (FDA) oversight must comply with FDA regulations regarding advertising and promotion.
  
  
• Any use of Publisher’s trademarks and its logo design, or copyrighted material for links to and from a Publisher website must be approved in advance by Publisher. Publisher does not endorse or support any product or organization linked to its website, nor is Publisher responsible for the content of any website promoted in any advertisement appearing at a Publisher website.
  
  
• All advertisements at RFPPL.CO.IN served on article pages are served on a random basis, in rotation with Red Flower Publication advertising and recruitment advertising. The random placement algorithm does not permit any commercial ad to be targeted to any specific article or any specific user or groups of users. Advertisers have no advance knowledge of and no control over ad placement. Neither the Publisher nor its publications endorse any company, product, or service.
  
  
• Recruitment ads must be nondiscriminatory and comply with all applicable laws and regulations. Ads that discriminate against applicants based on sex, age, race, religion, marital status or physical handicap will not be accepted. Non-India recruitment advertisers are required to confirm in writing that they are equal opportunity employers.

Online Cancellation Policies

Advertiser may cancel the entire Insertion Order, or any portion thereof, as follows:
Run-Of-Site Banner Programs:

• On written notice to Publisher given 21 or more days before the start date. With cancellations inside 21 days of the start date, advertiser will be responsible for 50% of the Insertion Order amount that was reserved for delivery.
  
  
• Flat fee-based or fixed placement programs (including, but not limited to, Roadblocks, Specialty Packs, and other Sponsorships:
  
  
• On written notice to Publisher given 30 or more days before the start date. With cancellations inside 30 days of the start date, advertiser will be responsible for 50% of the IO amount that was reserved for delivery.
  
  

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Red Flower Publication recognizes the multiplicity of financial and other conflicts confronting authors, referees, and editors. Red Flower Publication adopted a policy in August 2008 that does not aim to eliminate conflict but to manage it. The most important element of our policy is that all authors, members, referees, and editors must disclose any association that poses or could be perceived as a financial or intellectual conflict of interest in connection with the manuscript.

Authors are required during submission of their manuscripts to complete the online declaration form, to disclose any conflict of interest, and to acknowledge all funding sources supporting the work. The corresponding author must ensure that all authors have been asked to disclose any conflicts of interest.

When asked to evaluate a manuscript, reviewers and editors must disclose any association that poses a conflict of interest in connection with the manuscript. Recent collaborators, defined as people who have coauthored a paper or were a principal investigator on a grant with any of the authors within the past 48 months, must be excluded as editors and reviewers. Referees and editors are asked to recues themselves from handling a paper if the conflict makes them unable to make an impartial scientific judgment or evaluation. A referee or editor who has a conflict but believes that it does not preclude his or her making a proper judgment must disclose to the journal the nature of the conflict.

Divulging a potential conflict usually does not invalidate the research or the comments of a referee or editor; it simply provides the reader information necessary to independently assess the work. A conflict of interest includes a financial association or relationship that could influence the objectivity, integrity, or interpretation of a publication. Such conflicts of interest include relationships with corporations whose products or services are related to the subject matter of the article. These relations include employment, substantive ownership of stock or mutual funds, membership on a standing advisory council or committee, service on the board of directors, or public association with the company or its products. Other areas of conflict of interest could include receiving consulting fees, patent filings, serving as a paid spokesperson, or providing services in exchange for honoraria. Other examples of possible conflicts include past or present association as thesis advisor or thesis student, or a family relationship, such as a spouse, domestic partner, or parent–child relationship.

When a conflict of interest is disclosed either by the author or editor, a footnote describing the conflict will be included with the published article.

Red Flower Publication reserves the right to publish an erratum disclosing conflict(s) of interest related to a previously published paper. Authors, referees, or editors who have deliberately or recklessly failed to disclose conflicts of interest may receive sanctions, including being banned from publishing in Red Flower Publication for a period of time.

This policy applies to all material published in Red Flower Publication including research articles, Perspectives, Editorials, Reviews, Colloquium Papers, and Commentaries. For clarification of the policy, please see http://rfppl.co.in/article_submission_system.php?mid=5 or contact us at author@rfppl.co.in

Conflict of Interest Policy

Red Flower Publication recognizes the multiplicity of financial and other conflicts confronting authors, referees, and editors. Red Flower Publication adopted a policy in August 2008 that does not aim to eliminate conflict but to manage it. The most important element of our policy is that all authors, members, referees, and editors must disclose any association that poses or could be perceived as a financial or intellectual conflict of interest in connection with the manuscript.

Authors are required during submission of their manuscripts to complete the online declaration form, to disclose any conflict of interest, and to acknowledge all funding sources supporting the work. The corresponding author must ensure that all authors have been asked to disclose any conflicts of interest.

When asked to evaluate a manuscript, reviewers and editors must disclose any association that poses a conflict of interest in connection with the manuscript. Recent collaborators, defined as people who have coauthored a paper or were a principal investigator on a grant with any of the authors within the past 48 months, must be excluded as editors and reviewers. Referees and editors are asked to recues themselves from handling a paper if the conflict makes them unable to make an impartial scientific judgment or evaluation. A referee or editor who has a conflict but believes that it does not preclude his or her making a proper judgment must disclose to the journal the nature of the conflict.

Divulging a potential conflict usually does not invalidate the research or the comments of a referee or editor; it simply provides the reader information necessary to independently assess the work. A conflict of interest includes a financial association or relationship that could influence the objectivity, integrity, or interpretation of a publication. Such conflicts of interest include relationships with corporations whose products or services are related to the subject matter of the article. These relations include employment, substantive ownership of stock or mutual funds, membership on a standing advisory council or committee, service on the board of directors, or public association with the company or its products. Other areas of conflict of interest could include receiving consulting fees, patent filings, serving as a paid spokesperson, or providing services in exchange for honoraria. Other examples of possible conflicts include past or present association as thesis advisor or thesis student, or a family relationship, such as a spouse, domestic partner, or parent–child relationship.

When a conflict of interest is disclosed either by the author or editor, a footnote describing the conflict will be included with the published article.

Red Flower Publication reserves the right to publish an erratum disclosing conflict(s) of interest related to a previously published paper. Authors, referees, or editors who have deliberately or recklessly failed to disclose conflicts of interest may receive sanctions, including being banned from publishing in Red Flower Publication for a period of time.

This policy applies to all material published in Red Flower Publication including research articles, Perspectives, Editorials, Reviews, Colloquium Papers, and Commentaries. For clarification of the policy, please see http://rfppl.co.in/article_submission_system.php?mid=5 or contact us at author@rfppl.co.in

Published Statement of Informed

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Online Cancellation Policies

Advertiser may cancel the entire Insertion Order, or any portion thereof, as follows:
Run-Of-Site Banner Programs:

• On written notice to Publisher given 21 or more days before the start date. With cancellations inside 21 days of the start date, advertiser will be responsible for 50% of the Insertion Order amount that was reserved for delivery.
  
  
• Flat fee-based or fixed placement programs (including, but not limited to, Roadblocks, Specialty Packs, and other Sponsorships:
  
  
• On written notice to Publisher given 30 or more days before the start date. With cancellations inside 30 days of the start date, advertiser will be responsible for 50% of the IO amount that was reserved for delivery.
  
  

Human and Animal Rights

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Online Journal Site

Why go online

• Researchers, as authors, require access to the largest possible audience to disseminate their findings; researchers, as readers, need the broadest possible access to the relevant literature
• No time lag: An article can be "published" -- posted on the Web -- as soon as it is accepted and prepared for publication
• Faster dissemination of scientific information by expediting peer review, editorial and production work, and distribution
• Interactivity: Enabling letters to the editor and discussions concerning articles to be created and distributed online and linked to the articles in question
• Reference linking: Linking to other electronic information, such as links between reference citations and article abstracts and between references to material on the Web and the remote sites themselves
• No space limitations and no length limitations: Add extra on the site and save print cost
• Articles available online via Open Access have higher impact rates than proprietary online and print articles

Beyond a simple website

Putting up a simple HTML or PDF-based website is not enough, a complete journal site needs more

• Facility to conduct an extensive search across the full text of multiple journals.
• Facility to submit comments or remarks on published article
• Ability to go to other sites via reference and external linking
• Linking from other sites so that visitors can reach this site including from PubMed
• Good ranking with search engines enabling people to find your site
• Moving with internatioal trend: Metatags (e.g. DC metadata), user statistics (e.g. similar to COUNTER code), site structure (e.g. OepnURL), multiple mirroring (e.g. archiving at OAI compliant servers), and more
• Future-readiness with changing norms and technology should be able to adapt quickly

Unique features

• Mobile / hand-held device optimization
• Linking from PubMed, DOAJ, Cross Ref, etc.
• Citation tracking and citation alerts
• Linking for bacterial species names and eponyms
• Revenue from AdSense, sales through secondary aggregating agencies, ALJC, etc.
• Translation into multiple languages
• Providing electronic data to bibliographic agencies such as PubMed, ISI, CABI, SCOPUS, DOAJ, etc.

Check suitable journal for your article

Coming soon

Author Registration & Submission

Visit here

Types of Manuscripts

Covering Letter

Disclose all possible conflicts of interest (e.g., funding sources for consultancies or studies of products). A brief indication of the importance of the paper to the concerned field of research is helpful in gaining appropriate peer review.

Copyright Form

All manuscripts are considered to be the property of from the time of submission. If is not publishing the paper, releases its rights therein at the time the manuscript is rejected following editorial/peer review or retracted by the authors. Manuscripts published in become the sole property of, with all rights in copyright reserved to.

The corresponding author, on behalf of all authors, signs a copyright transfer form.

Download Copyright Form

Disclaimer and Copyrights

The entire contents are protected under international copyrights. The Journal, however, grants to all users a free right of access to and permission to copy, the published articles. Important notice on reuse, reproduction or commercial use:

• Contents of this site, partial or as a whole, should not be included in a framed web page.
• Contents of this site, partial or as a whole, should not be included in a password protected site or a site which requires registration, even if free.
• Contents of this site, partial or as a whole, should not be included in a site which charges for other contents but provides the content from this site for free.
• For purchase of reprints, printable PDF or commercial reuse please contact Red Flower Publications or the executive editor of the .

All material published in the journal undergoes peer review to ensure fair balance, objectivity, independence, and relevance to educational need. Neither the editors of Journal title, nor its publishers, nor any other party involved in the preparation of material contained in represent or warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such material. Patients and consumers reading articles posted on the website of Journal title should review the information carefully with their professional healthcare provider. The information is not intended to replace medical advice offered by the physicians. Journal title and its publishers make no representations or warranties with respect to any treatment, action, or application of medication or preparation by any person following the information offered or provided. The Journal title and its publishers will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising there from.

The advertisers who purchase Banners on the have no influence on editorial content or presentation. The posting of particular Banners does not imply endorsement of the product (so) or the company selling them by the Journal title or its Editors.

This may contain links to web sites operated by other parties. These links are provided purely for educational purpose. Such links do not imply Journal title's endorsement of material on any other site and disclaims all liability with regard to your access of such linked web sites.

Contributors' form

Author-Suggested Reviewers

The authors are encouraged to suggest individuals who specialize in the topic(s) your manuscript to be considered to review. You may suggest maximum of 5 reviewers, with full contact details including phone numbers, mobile number and email address.

Author Checklist

In order to maintain quality and consistency in publications, we ask you to perform the following checklist prior to submitting your final proof for publication:

• Include the original, hard copy of Author’s  Transfer of Copyright signed by each author
• Thoroughly check the reference style as mentioned above.
• Thoroughly check the article for correct grammar, in particular: spelling of names, affiliations, any symbols, equations, etc.
• Provide laser printed hard copies of all figures and graphics in black and white or colour (If any)
• Submit a proof corrected with RED INK ONLY/track changes or as directed by the editor handling your manuscript.

Send the Corrected Proof, Copyright Transfer Form, Subscriptions (If any) with covering letter in a single envelope to the following address

Important Contact Details

By Surface mail :

Editorial Office

By e mail : redflowerppl@vsnl.net

Web : www.rfppl.co.in

Correction and retraction policy

Red Flower Publication recognizes the importance of the integrity and completeness of the scholarly record to researchers and librarians and attaches the highest importance to maintaining trust in the authority of its electronic archive.

Red Flower Publication's policy

It is a general principle of scholarly communication that the editor of a learned journal is solely and independently responsible for deciding which articles submitted to the journal shall be published. In making this decision the editor is guided by policies of the journal's editorial board and constrained by such legal requirements in force regarding libel, copyright infringement and plagiarism. An outcome of this principle is the importance of the scholarly archive as a permanent, historic record of the transactions of scholarship. Articles that have been published shall remain extant, exact and unaltered as far as is possible. However, very occasionally circumstances may arise where an article is published that must later be retracted or even removed. Such actions must not be undertaken lightly and can only occur under exceptional circumstances.

This policy has been designed to address these concerns and to take into account current best practice in the scholarly and library communities. As standards evolve and change, we will revisit this issue and welcome the input of scholarly and library communities. We believe these issues require international standards and we will be active in lobbying various information bodies to establish international standards and best practices that the publishing and information industries can adopt.

Article Withdrawal

Only used for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Articles in Press (articles that have been accepted for publication but which have not been formally published and will not yet have the complete volume/issue/page information) that include errors, or are discovered to be accidental duplicates of other published article(s), or are determined to violate our journal publishing ethics guidelines in the view of the editors (such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like), may be "Withdrawn" from us. Withdrawn means that the article content (HTML and PDF) is removed and replaced with a HTML page and PDF simply stating that the article has been withdrawn according to the Red Flower Publication Policy on Article in Press Withdrawal with a link to the current policy document.

Article Retraction

Infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Occasionally a retraction will be used to correct errors in submission or publication. The retraction of an article by its authors or the editor under the advice of members of the scholarly community has long been an occasional feature of the learned world. Standards for dealing with retractions have been developed by a number of library and scholarly bodies, and this best practice is adopted for article retraction by Red Flower Publications:

• A retraction note titled "Retraction: [article title]" signed by the authors and/or the editor is published in the paginated part of a subsequent issue of the journal and listed in the contents list.
• In the electronic version, a link is made to the original article.
• The online article is preceded by a screen containing the retraction note. It is to this screen that the link resolves; the reader can then proceed to the article itself.
• The original article is retained unchanged save for a watermark on the .pdf indicating on each page that it is "retracted."
• The HTML version of the document is removed.

Article Removal: Legal limitations

In an extremely limited number of cases, it may be necessary to remove an article from the online database. This will only occur where the article is clearly defamatory, or infringes others legal rights, or where the article is, or we have good reason to expect it will be, the subject of a court order, or where the article, if acted upon, might pose a serious health risk. In these circumstances, while the metadata (Title and Authors) will be retained, the text will be replaced with a screen indicating the article has been removed for legal reasons.

Article Replacement

In cases where the article, if acted upon, might pose a serious health risk, the authors of the original article may wish to retract the flawed original and replace it with a corrected version. In these circumstances the procedures for retraction will be followed with the difference that the database retraction notice will publish a link to the corrected re-published article and a history of the document.

Last Updated on 04 October, 2023

Sending a Revised Manuscript

The authors revise the manuscript as advised by reviewers and submit the revised version. Typically, at this stage, authors are advised to prepare the manuscript by closely following the journal�s instructions about style and format and to submit the manuscript in electronic form.

Reprints and Proofs

Covering Letter

Disclose all possible conflicts of interest (e.g., funding sources for consultancies or studies of products). A brief indication of the importance of the paper to the concerned field of research is helpful in gaining appropriate peer review.

Author Registration & Submission

Visit here

Author-Suggested Reviewers

The authors are encouraged to suggest individuals who specialize in the topic(s) your manuscript to be considered to review your manuscript. You may suggest maximum of 5 reviewers, with full contact details including phone numbers, fax number and email address.

Copyright Form

All manuscripts are considered to be the property of from the time of submission. If is not publishing the paper, releases its rights therein at the time the manuscript is rejected following editorial/peer review or retracted by the authors. Manuscripts published in become the sole property of, with all rights in copyright reserved to.

The corresponding author, on behalf of all authors, signs a copyright transfer form.

Download Copyright Form

Preparation of Manuscript

Submission of Manuscript

Author Checklist

In order to maintain quality and consistency in publications, we ask you to perform the following checklist prior to submitting your final proof for publication:

• Include the original, hard copy of Author’s  Transfer of Copyright signed by each author
• Thoroughly check the reference style as mentioned above.
• Thoroughly check the article for correct grammar, in particular: spelling of names, affiliations, any symbols, equations, etc.
• Provide laser printed hard copies of all figures and graphics in black and white or colour (If any)
• Submit a proof corrected with RED INK ONLY/track changes or as directed by the editor handling your manuscript.

Send the Corrected Proof, Copyright Transfer Form, Subscriptions (If any) with covering letter in a single envelope to the following address

Important Contact Details

By Surface mail :

Editorial Office

By e mail : redflowerppl@vsnl.net

Web : www.rfppl.co.in

Types of Manuscripts

Protection of Patients' Rights

Sending a revised manuscript

The authors revise the manuscript as advised by reviewers and submit the revised version. Typically, at this stage, authors are advised to prepare the manuscript by closely following the journal's instructions about style and format and to submit the manuscript in electronic form.

Reprints and proofs

Disclaimer and Copyrights

Contributors' form

Download Instructions

These ready to use templates are made to help the contributors write as per the requirements of the Journal.

Save the templates on your computer and use them with a word processor program. 
Click open the file and save as the manuscript file.

In the program keep 'Document Map' and 'Comments' on from 'View' menu to navigate through the file. 


Download Template for Original Articles/ABSTRACT Reports. (.DOT file)

Download Template for Case Reports.  (.DOT file)

Download Template for Review Articles.  (.DOT file)

Download Template for Letter to the Editor.  (.DOT file)

Download Template for clinical image.  (.DOT file)

Download Template for rapid communication.  (.DOT file)

Download Template for short report.  (.DOT file)

Article Withdrawal

Reprints Rates

Reprints Order Form

Terms to use of contents

The following Terms of Use govern use by all Users of Red Flower Publications contents (or any successor thereto) and the electronic edition of the products subscribed to by an Authorized User or the Authorized User's institution (the “Customer”). Please read the following carefully because by using Red Flower Publications contents you are agreeing to abide by these Terms of Use.

Your institution may have a license which permits you additional uses; contact your institution's librarian/administrator for more information. If you or your institution entered into a license with Red Flower Publications (the “License”), the terms of the License control in the event of any discrepancy between it and these Terms of Use.

Copyright

The Electronic Products, Red Flower Publications and the Intellectual Property Rights contained therein are protected by law. As a User, you have certain rights specified below; all other rights are reserved.

Definitions

Authorized Users – As defined in your applicable license.

Electronic Products - All products, services and content available in Red Flower Publications.

Intellectual Property Rights  – These rights include, without limitation, patents, trademarks, trade names, design rights, copyright (including rights in computer software), database rights, rights in know-how and other intellectual property rights, in each case whether registered or unregistered, which may subsist anywhere in the world.

Licensed Electronic Products – The Electronic Products which the Customer has licensed.

Users – Users of Red Flower Publications regardless of whether they are Authorized Users or Customer.

Red Flower Publications - The online service (or any successor thereto) available from Red Flower Publications or its affiliates including all products, services and features offered via the service. Certain products and services may be delivered from other platforms. The terms and conditions hereof are equally applicable to those products and services.

Rules of Use

1. To make Red Flower Publications and the Electronic Products useful, the following rules apply:

Users may browse all Tables of Content for all Electronic Products on Red Flower Publications, regardless of what Licensed Electronic Products the Customer subscribes to, and search the entire database of Tables of Content and abstracts. For most publications, Users may browse the abstracts as well.

Customers and their Authorized Users will have access to the full text of the Licensed Electronic Products covered by the applicable License. Customers and their Authorized Users may download, search, retrieve, display and view, copy and save to a secure network or other electronic storage media and store or print out single copies of individual articles or items for their own personal use, scholarly, educational or scientific research or internal business use. Customers and Authorized Users may also transmit such material to a third-party colleague in hard copy or electronically for personal use or scholarly, educational, or scientific research or professional use but in no case for re-sale, systematic distribution, e.g. posting on a listserv, network (including scientific social networks) or automated delivery, or for any other use (including distribution through social networking websites and scholarly collaboration networks, except for those that have agreed to Red Flower Publication’s Article Sharing Policy and solely in accordance therewith). In addition, Authorized Users have the right to use, with appropriate credit, figures, tables and brief excerpts from individual articles in the Licensed Electronic Product(s) in their own scientific, scholarly and educational works.

All Users have the option to create a My Profile Page which will allow them to create links to Electronic Product(s), articles of interest and search criteria which may be reused by them and manage their custom e-mail alerting services. In order to do so, Users must register. During the registration process, Users will select and register a user name and password which they must keep confidential and not disclose to or share with anyone else.

2. Except as provided above or with respect to material published on an open access basis, Users may not copy, distribute, transmit or otherwise reproduce, sell or resell material from Electronic Product(s); store such material in any form or medium in a retrieval system; download and/or store an entire issue of an Electronic Product or its equivalent; or transmit such material, directly or indirectly, for use in any paid service such as document delivery or list serve, or for use by any information brokerage or for systematic distribution, whether or not for commercial or non-profit use or for a fee or free of charge.
3. Users agree not to remove, obscure or modify any copyright or proprietary notices, author attribution or any disclaimer as they appear on Red Flower Publications. Users may not integrate material from the Electronic Product(s) with other material or otherwise create derivative works in any medium. However, brief quotations for purposes of comment, criticism or similar scholarly purposes are not prohibited herein.
4. Users may not do anything to restrict or inhibit any other User's access to or use of Red Flower Publications and the Electronic Product(s).
5. If a User refuses or fails to abide by these Terms of Use or violates any other terms of this Agreement, Red Flower Publications reserves the right in its sole discretion to suspend or terminate their access to Red Flower Publications and the Electronic Products immediately without notice, in addition to any other available remedies.
6. Users shall not have the right to incorporate any material from the Electronic Products into any institutional or other repository under any circumstances without Red Flower Publication’s prior written approval (including social networking websites and scholarly collaboration networks, except for those that have agreed to Red Flower Publication’s Article Sharing Policy and in accordance therewith).

Additional Terms

Red Flower Publications is not responsible for any charges associated with accessing Red Flower Publications and the Electronic Products, including, but not limited to, any computer equipment, telephone or internet connections and access software.

Upon payment of an invoice, the products in the invoice are covered by the Customer’s License on the terms and conditions therein.

Red Flower Publications may modify any of these terms and conditions at any time by providing notice on Red Flower Publications. A User’s continued use of Red Flower Publications shall be conclusively deemed acceptance of such modification.

Red Flower Publications may provide links to third-party websites. Where such links exist, Red Flower Publications disclaims all responsibility and liability for the content of such third-party websites. Users assume the sole responsibility for the accessing of third-party websites and the use of any content appearing on such websites.

Privacy and Data Protection Policy

Red Flower Publication recognizes the importance of protecting the information it collects in the operation of Red Flower Publications and will act in compliance with the Privacy Policy.

Warranty Limitations

RED FLOWER PUBLICATIONS AND THE ELECTRONIC PRODUCTS AND ALL MATERIALS CONTAINED THEREIN ARE PROVIDED ON AN "AS IS" BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, WARRANTIES OF TITLE, OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE; THE USE OF THE ELECTRONIC PRODUCTS, RED FLOWER PUBLICATIONS AND ALL MATERIALS IS AT THE USER'S OWN RISK; ACCESS TO RED FLOWER PUBLICATIONS AND THE ELECTRONIC PRODUCTS MAY BE INTERRUPTED AND MAY NOT BE ERROR FREE; AND NEITHER RED FLOWER PUBLICATION NOR ANYONE ELSE INVOLVED IN CREATING, PRODUCING OR DELIVERING THE ELECTRONIC PRODUCTS OR THE MATERIALS CONTAINED IN RED FLOWER PUBLICATIONS, SHALL BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES ARISING OUT OF THE USER'S USE OF OR INABILITY TO USE RED FLOWER PUBLICATIONS, THE ELECTRONIC PRODUCTS AND ALL MATERIALS CONTAINED THEREIN.

Article sharing policy

Scholarly research is by its nature collaborative. Teams of researchers and scientists in the academic and not-­‐for-­‐profit sectors share experience, expertise, and facilities in order to advance human knowledge and understanding. Nowhere is this more evident than in the sharing of scholarly articles – the majority of which include multiple authors, often from different institutions and countries. Sharing of articles and supplementary material is thus an important factor in advancing research.

As research groups have become more interdisciplinary and international, such sharing has increased, enabled by the rise of internet tools and technologies. Scholarly collaboration networks offer researchers the opportunity to discover and share articles and data, but the sharing experience can be inefficient, inconsistent, hindered by legal uncertainty and frustrating for academic researchers, institutions, collaboration networks and publishers.

We would like to make sharing of subscription and licensed content simple and seamless for academic researchers so that it is consistent with access and usage rights associated with articles while enhancing collaboration. We believe publishers and scholarly collaboration networks can work together to facilitate sharing, which benefits researchers, institutions, and society as a whole, with a core set of principles that maximize this experience for all.

Open Access publication provides one route to enable sharing but does not address sharing of subscription and licensed content. These voluntary principles are intended to address that gap, and be complementary to, not as a substitute for, Open Access publication or self-­‐archiving. They are also not meant to address sharing by and between commercial organizations.

The signatories to these principles believe:

• Publishers have a core commitment to facilitate the dissemination and discovery of their authors’ scholarly articles.
• Sharing should be allowed within research collaboration groups, namely groups of scholars or researchers invited to participate in specific research collaborations. Such groups would:

1. be of the size that is typical for research groups of that discipline
2. only share articles within and for the purposes of the group
3. allow article sharing between subscribers and non-­‐subscribers within the group
4. include commercial researchers, subject to publisher policy or appropriate licensing
5. include members of the wider public participating for the purposes of the group

• Publishers and libraries should be able to measure the amount and type of sharing, using standards such as COUNTER, to better understand the habits of their readers and quantify the value of the services they provide.

Initiatives to facilitate sharing should:

• be based on standards to support the tools and platforms required by researchers
• be open to all participants supporting these principles
• integrate access and usage rights and data reporting into research workflows
• ensure that usage and activity data is managed in a manner consistent with personal privacy and security laws and requirements
• Public posting of article metadata and open access articles in scholarly collaboration networks should be encouraged.
• Publisher policies on research collaboration group sharing and public posting of articles should be clear and easily discoverable, and we call on publishers to work toward this goal.